Meet our fantastic team. Together, we work towards our mission of freeing you from viruses.
Clarissa Koch
Research
Sagrario Arias Rivas
Research Partnerships
Anna Beukenhorst
Scientific Data
Kristian Bolk
People
Mike Shaw
Business Development
Dennis de Vlaam
Operations
Ilse Haisma
Research Operations
Ian McGuiness
Regulatory Affairs
Stephen Mc Nally
Quality
Amanda Motto
Finance & Control
Kerri Pierz
Market Development
Robin Rogiers
Medical
Chris Dachwitz
IT
René Verdonk
Program Management
Marianne Wooning
Clinical Operations
Bertjan Ziere
Preclinical & CMC
Our Supervisory Board
Dinko Valerio
Founder and Chair of the Supervisory Board
John Martin (In memoriam)
Former CEO Gilead Sciences
Onno van de Stolpe
Former CEO Galapagos.
James Shannon
Former CMO GSK and Global Head of Development at Novartis
Richard Whitley
Professor in Pediatrics and Microbiology, Medicine and Neurosurgery at University of Alabama
René Russo
Pharm.D., Chief Executive Officer of Xilio Therapeutics
David Schenkein
General Partner GV
Stephen Knight
President and Managing Partner F-Prime Capital
Eli Casdin
Chief Investment Officer and Founder Casdin Capital
Khoo Shih
Chief Executive Officer ClavystBio